2003
DOI: 10.1021/bi027417x
|View full text |Cite
|
Sign up to set email alerts
|

Binding of Nonphysiological Protein and Peptide Substrates to Proteases:  Differences between Urokinase-Type Plasminogen Activator and Trypsin and Contributions to the Evolution of Regulated Proteolysis

Abstract: Understanding the regulation of physiological processes requires detailed knowledge of the recognition of substrates by enzymes. One of the most productive model systems for the study of enzyme-substrate interactions is the serine protease family; however, most studies of protease action have used small substrates that contain an activated, non-natural scissile bond. Because few kinetic or structural studies have used protein substrates, the physiologically relevant target of most proteases, it seems likely th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2003
2003
2015
2015

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 52 publications
(106 reference statements)
0
2
0
Order By: Relevance
“…There are now multiple examples of proteases that cleave physiological protein substrates orders of magnitude faster than the best known active site interacting peptide substrate. Urokinase-type plasminogen activator, for example, can cleave the physiological substrate plasminogen more than 100-fold faster than the best known peptide substrates selected using substrate phage display (e.g., PFGR↑SA) (Bergstrom et al, 2003). Although the precise mechanisms used by proteases to cleave physiological substrates so efficiently remain unclear, a subset of proteases can recognize an extended linear peptide substrate using multiple interacting exosites in a manner similar to thrombin.…”
Section: Discussionmentioning
confidence: 99%
“…There are now multiple examples of proteases that cleave physiological protein substrates orders of magnitude faster than the best known active site interacting peptide substrate. Urokinase-type plasminogen activator, for example, can cleave the physiological substrate plasminogen more than 100-fold faster than the best known peptide substrates selected using substrate phage display (e.g., PFGR↑SA) (Bergstrom et al, 2003). Although the precise mechanisms used by proteases to cleave physiological substrates so efficiently remain unclear, a subset of proteases can recognize an extended linear peptide substrate using multiple interacting exosites in a manner similar to thrombin.…”
Section: Discussionmentioning
confidence: 99%
“…There is currently a lot of interest in understanding the molecular recognition events associated with MAPKs, because docking domains are thought to play a major role in determining the specificity of substrate-ligand and protein-ligand interactions [13][14][15]. A growing number of enzymes are thought to utilize docking domains, which are substrate recognition elements lying outside the active site of the enzyme and which govern the formation of an enzyme-substrate complex [16][17][18][19][20][21][22][23]. Several years ago, we showed that despite the presence of docking domains on p38 MAPKa, which could tether a protein substrate and facilitate multiple phosphorylations in one collision, p38 MAPKa phosphorylates ATF2D115 on Thr69 and Thr71 in a nonprocessive manner [24].…”
mentioning
confidence: 99%